{
  "meta": {
    "id": "test45",
    "title": "SLE, Juvenile Dermatomyositis & Scleroderma",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Acrodermatitis enteropathica is associated with which of these classical forms of dermatitis in children?",
      "options": [
        {
          "label": "A",
          "text": "Scalp dermatitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Periorbital dermatitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Periumbilical dermatitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Peri orificial dermatitis",
          "correct": true
        }
      ],
      "correct_answer": "D. Peri orificial dermatitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Peri orificial dermatitis Acrodermatitis enteropathica is an autosomal recessive disorder associated with defective intestinal absorption of zinc. It is associated with alopecia, dermatitis, and diarrhea. Classical dermatitis seen in acrodermatitis enteropathica is Peri or artificial dermatitis, classically present around the mouth and perineum.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b4ec7ad3",
      "audio": ""
    },
    {
      "text": "A Mother brought her 6-month-old baby girl to the OPD due to the rash as shown in the picture for the last 7 days. The mother also complained that the rash gets worse in the sunlight. On further examination, oral ulcers were present in the buccal mucosa. On investigation, there was a presence of anti-ds DNA Ab. & ANA Ab. Which among these is the specific diagnosis of the baby\u2019s condition?",
      "options": [
        {
          "label": "A",
          "text": "Oligoarthritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Systemic Lupus Erythematosus",
          "correct": true
        },
        {
          "label": "C",
          "text": "Drug-induced lupus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Subacute Cutaneous Lupus",
          "correct": false
        }
      ],
      "correct_answer": "B. Systemic Lupus Erythematosus",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1682882695328-QTDK005002IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Systemic Lupus Erythematosus Here, the diagnosis is SLE ( Systemic Lupus Erythematosus). It is an autoimmune disorder characterized by inflammation of connective tissues and blood vessels resulting in multisystem involvement.</p>\n<p><strong>Highyeild:</strong></p><p>The hallmark of SLE is the presence of antinuclear antibodies (ANA). Childhood SLE is usually more severe than in adults. Diagnosis of SLE is done by Systemic Lupus International Collaborating Clinics (SLICC) criteria:- SLICC Classification Criteria for SLE Requirements: \u2265  4 criteria (at least 1 clinical and 1 laboratory criteria) OR biopsy-proven lupus nephritis with positive ANA or anti-dsDNA Clinical criteria Acute cutaneous lupus Chronic cutaneous lupus Oral or nasal ulcers Non-scarring alopecia Arthritis Serositis Renal involvement Neurologic involvement Hemolytic anemia Leukopenia Thrombocytopenia (<100,000/cu mm\u00b3) Immunologic criteria Antinuclear antibody (ANA Anti-dsDNA Anti-Smith Antiphospholipid antibody Low complement (C3,C4,CH50) Direct Coombs' test (do not count in presence of hemolytic anemia) The Malar rash is pathognomic of SLE . It involves cheeks, bridge of nose and lower eyelids but spares the nasolabial folds. Oral ulcerations may involve the buccal mucosa or palate and are usually painless. Some children may have prominent frontal alopecia.Arthritis is generally mild & non-erosive. Renal involvement is a dreaded complication of SLE & one of the commonest Causes of mortality in children. Lupus Nephritis is conventionally classified as follows: CLASS 1: Minimal Mesangial; CLASS 2: Mesangial Proliferative; CLASS 3: Focal Proliferative; CLASS 4: Diffuse Proliferative; CLASS 5: Membranous; CLASS 6: Advanced Sclerosing.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Oligoarthritis, is the most frequent type of JIA. Four or fewer joints(usually large)are affected during the first 6 months of disease.Joint swelling is the usual complaint. More common in young girls,typically 3-5 years of age. Asymmetric involvement of knee or ankle is characteristic. Small joints of hands & feet are not involved. Option: C. Drug-induced Lupus is more frequent than SLE. Anti-histone Antibody is present in this condition. Option: D. Subacute Cutaneous Lupus has the presence of Anti-Ro (SSA) Antibody which is not specific for SLE. It is associated with sjogren's syndrome , predisposes to subacute cutaneous lupus associated with decreased risk of nephritis.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4dadf8d1",
      "audio": ""
    },
    {
      "text": "A 6-month-old baby presented with features of SLE to your clinic. On examination further, Renal involvement was found to be associated with the disease & was detected as one of the most dreaded complications of SLE in children. Which of the following classes of lupus nephritis mentioned below requires the most aggressive forms of therapy?",
      "options": [
        {
          "label": "A",
          "text": "Minimal Mesangial & Mesangial Proliferative",
          "correct": false
        },
        {
          "label": "B",
          "text": "Focal Proliferative & Diffuse Proliferative",
          "correct": true
        },
        {
          "label": "C",
          "text": "Membranous & Advanced Sclerosing",
          "correct": false
        },
        {
          "label": "D",
          "text": "Membranous & Membrano proliferative",
          "correct": false
        }
      ],
      "correct_answer": "B. Focal Proliferative & Diffuse Proliferative",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Focal Proliferative & Diffuse Proliferative Renal involvement is a dreaded complication of SLE & one of the commonest causes of mortality in children.</p>\n<p><strong>Highyeild:</strong></p><p>Lupus Nephritis is conventionally classified as follows: CLASS 1: Minimal Mesangial; CLASS 2: Mesangial Proliferative; CLASS 3: Focal Proliferative; CLASS 4: Diffuse Proliferative; CLASS 5: Membranous; CLASS 6: Advanced Sclerosing. CLASS 3 and CLASS 4 Lesions (i.e., proliferative glomerulonephritis) require the most aggressive forms of therapy. Life-threatening complications (e.g. class 4 lupus nephritis, myocarditis, encephalopathy) require the use of i/v pulses of methylprednisolone(30mg/kg/day) for 3-5 days. The use of monthly pulses of IV cyclophosphamide(500mg/m2) has improved the long-term outcome in children with severe forms of lupus nephritis. Mycophenolate mofetil is increasingly being used for the therapy of severe forms of lupus nephritis.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - O ption: A. Minimal Mesangial & Mesangial Proliferative are CLASS 1& CLASS 2 of lupus nephritis, and these classes do not require aggressive forms of therapy. Option: C & D are also classes of lupus nephritis and these classes do not require aggressive forms of treatment. Membranous Nephropathy is seen in glomerulopathy associated with colon cancer or lung cancer, renal pathology in syphilis, and hepatitis B.Membrano Proliferative is seen in renal pathology in leprosy cases.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "728119db",
      "audio": ""
    },
    {
      "text": "On the evaluation of a 6-month-old baby, he was found to be diagnosed with SLE. He also had an attack of seizures 2 months back with altered sensorium. On investigating further, the findings are as mentioned below:- Direct Coomb\u2019s test \u2013( +)ve WBC \u2013 2500cells/microlitre LYMPHOCYTES- 500cells/microlitre in blood PLATELETS- 60000/microlitre of blood Low complement levels of C3 & C4. According to SLICC classification criteria for SLE, all of these Immunologic criteria are correct except?",
      "options": [
        {
          "label": "A",
          "text": "Anti-ds. DNA Antibody",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-smith Antibody",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-phospholipid Antibody",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti- centromere Antibody",
          "correct": true
        }
      ],
      "correct_answer": "D. Anti- centromere Antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Anti- centromere Antibody Anti- centromere Antibody is seen in CREST Syndrome i.e.,</p>\n<p><strong>Highyeild:</strong></p><p>C- calcinosis cutis i.e., calcium skin deposits R- Raynaud\u2019s phenomenon( A condition in which some areas of the body feel numb & cool in response to excessively cold weather.) E- esophageal dysmotility S- sclerodactyly T- telangiectasia These features are a heterogenous group of sclerodermas.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - O ption: A. Anti-ds. DNA Antibody is highly specific to SLE and usually correlates with the disease activity, nephritis & vasculitis. O ption: B. Anti-smith antibodies are a marker for CNS lupus. Also, specifically for SLE, no definite correlations. O ption: C. Anti-phospholipid Antibody is useful in the diagnosis of 3 tests available: ELISAs for cardiolipin & beta2 G1, Sensitive prothrombin time predisposes to clotting, fetal loss, and thrombocytopenia. Useful for detecting SLE patients. SLICC Classification Criteria for SLE Requirements:  \u2265 4 criteria (at least 1 clinical and 1 laboratory criteria) OR biopsy-proven lupus nephritis with positive ANA or anti-dsDNA Clinical criteria Acute cutaneous lupus Chronic cutaneous lupus Oral or nasal ulcers Non-scarring alopecia Arthritis Serositis Renal involvement Neurologic involvement Hemolytic anemia Leukopenia Thrombocytopenia (<100,000/cu mm\u00b3) Immunologic criteria Antinuclear antibody (ANA Anti-dsDNA Anti-Smith Antiphospholipid antibody Low complement (C3,C4,CH50) Direct Coombs' test (do not count in presence of hemolytic anemia)</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbfecef4",
      "audio": ""
    },
    {
      "text": "Aarav, a 6-week-old baby was brought to a pediatric clinic by his mother due to rashes on the cheek and bridge of the nose for 5 days. The baby was also having prominent frontal alopecia and cardiac manifestations. Upon investigation, a presence of typical anti-RO antibodies was found with congenital heart block. Which is the appropriate treatment therapy for this baby's condition?",
      "options": [
        {
          "label": "A",
          "text": "Gluco-corticoids and hydroxychloroquine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Prednisolone and NSAIDS",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rituximab & eculizumab",
          "correct": false
        },
        {
          "label": "D",
          "text": "Azathioprine and mycophenolate mofetil",
          "correct": false
        }
      ],
      "correct_answer": "A. Gluco-corticoids and hydroxychloroquine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Gluco-corticoids and hydroxychloroquine Based on the above case scenario this baby is having SLE. so appropriate treatment for this baby is Glucocorticoids and hydroxychloroquine as it is the mainstay of therapy. It is an autoimmune disorder characterized by inflammation of connective tissues and blood vessels resulting in multi-system involvement.</p>\n<p><strong>Highyeild:</strong></p><p>The Malar rash is pathognomic of SLE. It involves the cheeks, bridge of the nose , and lower eyelids but spares the nasolabial folds. Oral ulcerations may involve the buccal mucosa or palate and are usually painless. Some children may have prominent frontal alopecia. Arthritis is generally mild & non-erosive. anti-RO antibodies are present in the neonatal lupus especially those associated with congenital heart block. Renal involvement is a dreaded complication of SLE Prednisolone is started at doses of 1-2 mg/kg/day and gradually tapered over several months according to disease activity. low dose prednisolone (2.5-5 mg/day ) and hydroxychloroquine (5-6 mg/kg/day ) may need to be continued for several years depending on the clinical response.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Is prednisolone and NSAIDS, but they are not directly involved in the treatment of SLE. prednisolone is started at doses of 1-2 mg/kg/day and gradually tapered over several months according to disease activity. arthritis usually responds to NSAIDs. Option: C. Is rituximab & eculizumab . rituximab is a monoclonal antibody to CD 20 & has been found effective in situations like lupus nephritis, myocarditis, and encephalopathy. monoclonal antibodies like rituximab & eculizumab that deplete most B cells and are used to treat non-malignant hematological disorders like ITP, Anemia, polycythemia vera. these drugs are only used when there is no response to conventional drugs. Option: D. Is azathioprine & mycophenolate mofetil. these are immunosuppressive agents used in combination with glucocorticoids in severe skin lesions and organ involvement. they help to reduce the dose & toxicity of glucocorticoids.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "02ad041b",
      "audio": ""
    },
    {
      "text": "A 32-year-old woman brings her child to the pediatric OPD for evaluation of a hypercoagulative state along with venous & arterial thrombosis. On taking a history of the child, the doctor found out that he also had h/o DVT and features of livedo reticularis. Upon investigation, the laboratory findings are as follows: Prothrombin time(PT) \u2013 12sec Partial thromboplastin time(PTT) - >35 SEC Platelets- 1,00,000/microlitre. Which of the following antibodies is not useful in making a diagnosis in this condition?",
      "options": [
        {
          "label": "A",
          "text": "Anti- beta2 glycoprotein 1antibodies(Igm &IgG)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lupus anticoagulant",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti- beta2 microglobulin antibody",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anti-cardiolipin antibody(IgM & IgG)",
          "correct": false
        }
      ],
      "correct_answer": "C. Anti- beta2 microglobulin antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Anti- beta2 microglobulin antibody The given clinical history of a woman with a hypercoagulable state along with arterial & venous thrombosis and also with a h/o DVT , livedo reticularis , and thrombocytopenia suggests a diagnosis of Antiphospholipid syndrome(APS). Anti-beta2 microglobulin antibody is not useful in diagnosing this condition. It is found in SLE patients & is important in the lymphocytotoxic reaction of sera from patients with multiple myeloma, and lymphoma.</p>\n<p><strong>Highyeild:</strong></p><p>For the diagnosis of Antiphospholipid syndrome, a typical coagulation profile (normal prothrombin and partial thromboplastin time) and high titers of one or more of the following three antibodies should be demonstrated along with at least one clinical symptom of thrombosis : Anti- beta2 glycoprotein 1 antibodies (IgM & IgM) \u2013 OPTION (A) Lupus Anticoagulant (LA) \u2013most specific - OPTION (B) Anti-cardiolipin antibodies(IgM & IgG) \u2013 OPTION (D)</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dab79177",
      "audio": ""
    },
    {
      "text": "A 2-year-old baby presented with an erythematous rash over the dorsal aspect of MCP & PIP joints. The baby faces difficulty in standing and walking due to proximal muscle weakness. EMG shows evidence of Myopathy. The following finding was noted on examination as shown in image. What is the most probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "SLE",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dermatomyositis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Polymyositis",
          "correct": false
        },
        {
          "label": "D",
          "text": "DLE",
          "correct": false
        }
      ],
      "correct_answer": "B. Dermatomyositis",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/questionImage-1690955786527-QTDK005007IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Dermatomyositis In this patient most probable diagnosis is Dermatomyositis. Juvenile Dermatomyositis is a multisystem disease characterized by non-suppurative inflammation of striated muscle and skin and systemic vasculopathy. the Dx of JDM can be made on the bases of the following criteria : Characteristic heliotrope discoloration over upper eyelids or a scaly erythematous rash over the dorsal aspect of MCP & PIP joints. ( GOTTRON\u2019S PAPULES ) Symmetrical proximal muscle weakness An elevated level of muscle enzymes ( creatine kinase, alanine, and aspartate aminotransferase ) Electromyographic evidence of myopathy Muscle biopsy showing myonecrosis, myophagocytosis, and perifascicular atrophy</p>\n<p><strong>Highyeild:</strong></p><p>Other dermatological changes include edema over eyelids, photosensitivity, truncal rash, and calcinosis. MRI shows characteristic hyperintense signals on T 2 weighted images suggestive of muscle edema & inflammation, while T 1 weighted images show fibrosis, atrophy, and fatty infiltration.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. SLE is an autoimmune disorder characterized by inflammation of connective tissues and blood vessels resulting in multisystem involvement. The Malar rash is pathognomic of SLE. It involves the cheeks, bridge of the nose, and lower eyelids but spares the nasolabial folds. Oral ulcerations may involve the buccal mucosa or palate and are usually painless. Some children may have prominent frontal alopecia. Arthritis is generally mild & non-erosive. Option: C. Is Polymyositis an inflammatory myopathy most frequently associated with other autoimmune diseases. it also involved perivascular and endomysial infiltrates. unlike adults, pure polymyositis ( with no accompanying skin involvement ) is uncommon in children. Option: D. Is DLE. Discoid lesions are rare in childhood. oral ulcerations may involve buccal mucosa and palate and they are usually painless. arthritis is generally mild, always non-erosive.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c2839f98",
      "audio": ""
    },
    {
      "text": "Which of the following would help you to differentiate between polymyositis & dermatomyositis in a patient presenting with muscle weakness and evidence of myopathy?",
      "options": [
        {
          "label": "A",
          "text": "Erythematous rash",
          "correct": true
        },
        {
          "label": "B",
          "text": "Involvement of proximal muscle",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated creatine kinase & alanine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Muscle biopsy showing perifascicular atrophy",
          "correct": false
        }
      ],
      "correct_answer": "A. Erythematous rash",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Erythematous rash The presence of a Scaly, erythematous rash helps in differentiating between two conditions as it is only seen in dermatomyositis. Juvenile dermatomyositis is a multisystem disease characterized by non-suppurative inflammation of striated muscle and skin and systemic vasculopathy. the Dx of JDM can be made on the bases of the following criteria : Characteristic heliotrope discoloration over upper eyelids or a scaly erythematous rash over the dorsal aspect of MCP & PIP joints. ( GOTTRON'S PAPULES )</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Symmetrical proximal muscle weakness Option: C. An elevated level of muscle enzymes ( creatine kinase, alanine, and aspartate aminotransferase ) Electromyographic evidence of myopathy Option: D. Muscle biopsy showing myonecrosis, myophagocytosis and perifascicular atrophy Pure polymyositis is very uncommon in children and presents with no accompanying skin involvement. Thus rash is not present in polymyositis patients.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bfd738d0",
      "audio": ""
    },
    {
      "text": "A Pediatrician has diagnosed Dermatomyositis in a 3-yr. old baby with complaints of proximal myalgia, truncal rash & edema over the eyelids. The presence of which of these signs would be pathognomonic of this condition?",
      "options": [
        {
          "label": "A",
          "text": "Gottron\u2019s sign",
          "correct": false
        },
        {
          "label": "B",
          "text": "V-Sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gottron\u2019s papules",
          "correct": true
        },
        {
          "label": "D",
          "text": "Shawl sign",
          "correct": false
        }
      ],
      "correct_answer": "C. Gottron\u2019s papules",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Gottron\u2019s papules The presence of Gottron\u2019s papules is Pathognomonic of Dermatomyositis. They are erythematous to violaceous papules that occur symmetrically over the dorsal aspects of metacarpophalangeal & proximal interphalangeal joints.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option A. Gottron's sign, on the other hand, is erythematous rash over dorsal aspects of joints such as the knuckles, elbows, knees, and ankles. Option B. V-Sign is confluent macular erythema over the lower anterior neck and upper anterior chest. Option D. Shawl sign is the confluent macular erythema over the upper back and lateral aspect of arms. All of these signs are present in Dermatomyositis, but Gottron's papules & heliotrope rash are pathognomonic.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c0f7accb",
      "audio": ""
    },
    {
      "text": "A 6-Year-old girl presented with muscle weakness and pain over her shoulders. On examination, the rash shown in the image was noted. Positive titers of which of the following antibodies are associated with her condition?",
      "options": [
        {
          "label": "A",
          "text": "Anti-Jo 1 Antibody",
          "correct": true
        },
        {
          "label": "B",
          "text": "Anti- SRP Antibody",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-Mi-1 Antibody",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti- PM-Scl Antibody",
          "correct": false
        }
      ],
      "correct_answer": "A. Anti-Jo 1 Antibody",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1682882695428-QTDK005010IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Anti-Jo 1 Antibody The given clinical scenario and findings of Gottron\u2019s papules in the image as shown are suggestive of Dermatomyositis.</p>\n<p><strong>Highyeild:</strong></p><p>Positive titers of Anti- Jo 1 Antibody (OPTION A) are associated with interstitial lung disease, arthritis, and scaly, erythematous rashes in patients with dermatomyositis.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - O ption: B. Anti- SRP( anti- signal recognition protein) Antibody is associated with severe myositis. O ption: C. Anti- Mi-1 Antibody is not associated with dermatomyositis but instead Anti- Mi-2 Antibody is highly specific to dermatomyositis. O ption: D. Anti- PM- Scl Antibody is associated with overlapping myositis and scleroderma. Other autoantibodies seen in dermatomyositis are:- Anti- p155/140 or anti-transcription intermediary factor(TIF)- 1gamma \u2013 seen in cancer-associated myositis. Anti-MDA5 (anti-CADM 140) IS Associated with rapidly progressive lung disease and cutaneous ulcers.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc3c2507",
      "audio": ""
    },
    {
      "text": "A 10-yr. the old boy along with his mother came to the OPD with complaints of edema & rash over the upper eyelids associated with photosensitivity. On MRI, T1W Shows fibrosis & fatty infiltration, and T2W shows hyperintense signals suggestive of muscle edema & inflammation. On evaluating all the above findings, the doctor confirmed it to be a case of Dermatomyositis. What should be the appropriate treatment given to the boy in this case?",
      "options": [
        {
          "label": "A",
          "text": "Treatment with pulse IV cyclophosphamide(500mg/m2) monthly",
          "correct": false
        },
        {
          "label": "B",
          "text": "Treatment with methotrexate (15-25mg/m2/week) given s/c or orally daily for 5 days",
          "correct": false
        },
        {
          "label": "C",
          "text": "Treatment with pulse IV Methylprednisolone (30mg/kg/day) for 3-5 days followed by gradual tapering",
          "correct": true
        },
        {
          "label": "D",
          "text": "Treatment with rituximab, a CD 20 monoclonal antibody 500mg twice at 2 weeks intervals",
          "correct": false
        }
      ],
      "correct_answer": "C. Treatment with pulse IV Methylprednisolone (30mg/kg/day) for 3-5 days followed by gradual tapering",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Treatment with pulse IV Methylprednisolone (30mg/kg/day) for 3-5 days followed by gradual tapering Based on the above case scenario, the diagnosis is Dermatomyositis in a boy.</p>\n<p><strong>Highyeild:</strong></p><p>Based on the above case scenario, the diagnosis is Dermatomyositis in a boy. The appropriate treatment therapy given to the baby boy in this condition is with pulse IV methylprednisolone (30mg/kg/day) for 3-5 days followed by gradual tapering doses of oral prednisolone(1.5- 2mg/kg/day). Rapid tapering of steroids may result in disease relapse. Long-term prognosis is excellent,  if treatment is started early.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - O ption: A. Treatment with pulse IV cyclophosphamide(500mg/m2)monthly has considerably improved the long-term outcome in children with severe forms of lupus nephritis present in SLE. O ption: B. Treatment with methotrexate (15-25mg/m2/week) given s/c or orally daily for 5 days forms the mainstay of maintenance therapy in patients with dermatomyositis. However, it is used only if iv methylprednisolone is ineffective. The usual duration of therapy is 18-24 months. Option: D. Treatment with rituximab , a CD20 monoclonal antibody given 500mg twice at 2 weeks intervals is found to be effective in situations like lupus nephritis, myocarditis, and encephalopathy in SLE patients.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "371cad8b",
      "audio": ""
    },
    {
      "text": "Samar, a 6-yr. the old boy presents to you with hardening of skin and numbness of fingers & toes on exposure to cold environments. He also complains of muscle weakness and difficulty while walking & standing for a long duration. Investigations done reveal the following findings: ANA- Ab. positive Anti- Scl 70 Ab. positive Elevated creatine kinase &alanine Muscle biopsy showing perifascicular atrophy. What is the likely diagnosis of this condition?",
      "options": [
        {
          "label": "A",
          "text": "Systemic scleroderma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Overlap syndromes",
          "correct": true
        },
        {
          "label": "C",
          "text": "Localized sclerodermas",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pseudosclerodermas",
          "correct": false
        }
      ],
      "correct_answer": "B. Overlap syndromes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Overlap syndromes The above-given case has features of both systemic scleroderma & dermatomyositis, which points towards a diagnosis of Overlap syndromes.</p>\n<p><strong>Highyeild:</strong></p><p>This is a multisystemic overlap syndrome characterized by features of rheumatoid arthritis, systemic scleroderma, SLE, and dermatomyositis occurring in conjunction with high titers of anti-ribonucleoprotein(RNP) ANTIBODIES( SPECIFIC FOR U1 RNP). Nephritis is less common and less severe than SLE. Oral weekly Methotrexate is a useful therapeutic option.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - O ption: A. SYSTEMIC SCLERODERMA also known as systemic sclerosis, refers to the hardening of the It can be classified as follows: Systemic scleroderma (eg. Diffuse cutaneous, limited cutaneous) Overlap syndromes Option: C. Localized scleroderma(e.g morphea, linear scleroderma, eosinophilic fasciitis) Chemically induced scleroderma(e.g with polyvinyl chloride, pentazocine, bleomycin) Option: D. Pseudosclerodermas(e.g phenylketonuria, scleredema, progeria, and porphyria cutanea tarda) DIFFUSE CUTANEOUS SYSTEMIC SCLERODERMA is usually associated with visceral involvement including the GIT, heart, lungs & kidneys. Fetomaternal graft vs host reactions is also involved. The onset of the disease is insidious & difficult to recognize in the initial stages. The child presents with skin tightening(edema, atrophy, and acrosclerosis), Raynaud\u2019s phenomenon(blanching, cyanosis &erythema), soft tissue contractures, arthralgias, myalgias & dysphagia, and dyspnea.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "608d8618",
      "audio": ""
    },
    {
      "text": "Akshara, a school-going girl presents with complaints of thickening skin over her hands & fingers, dysphagia, and dyspnea. She also gives a history suggestive of Raynaud\u2019s phenomenon. On physical examination, it revealed reduced mobility. The presence of which of the following antibodies will confirm her diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Anti-nuclear Antibody",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-DNA topoisomerase I Antibody",
          "correct": true
        },
        {
          "label": "C",
          "text": "Anti-centromere Antibody",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti-cardiolipin Antibody",
          "correct": false
        }
      ],
      "correct_answer": "B. Anti-DNA topoisomerase I Antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Anti-DNA topoisomerase I Antibody The clinical features of skin thickening over hands & fingers, dysphagia, and dyspnea along with h/o Raynaud\u2019s phenomenon associated with reduced mobility in a girl is leading to a diagnosis of Diffuse cutaneous systemic scleroderma/sclerosis.</p>\n<p><strong>Highyeild:</strong></p><p>The presence of Anti- DNA topoisomerase I Antibody (scl-70) OPTION (B) & Anti- RNA polymerase III Antibodies will confirm the diagnosis of Diffuse cutaneous systemic scleroderma.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - O ption: A. The presence of Anti-nuclear Antibody (ANA) is positive in most cases of systemic sclerosis. The absence of this antibody indicates an alternate diagnosis. O ption: C. The presence of ANTI-CENTROMERE Antibody (ACA) is suggestive of a diagnosis of limited cutaneous systemic scleroderma. It is also considered a most specific test for CREST syndrome in systemic sclerodermas(C \u2013 Calcinosis cutis, R- Raynaud\u2019s phenomenon, E- Esophageal dysmotility, S- Sclerodactyly, T- Telangiectasia ) Option: D. The presence of Anticardiolipin Antibody is seen in SLE and APLA(Antiphospholipid antibody) syndromes.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "940714ce",
      "audio": ""
    },
    {
      "text": "A mid-school-going boy came with complaints of dysphagia, dyspnea, and heartburn with skin tightening leading to atrophy. His mother, who was accompanying him gave a h/o fetomaternal reaction which occurred in the past during her pregnancy. Based on all these findings, the boy is likely to be suffering from systemic sclerosis along with multi-organ involvement. Which of the following is not a component of CREST syndrome?",
      "options": [
        {
          "label": "A",
          "text": "CALCINOSIS CUTIS",
          "correct": false
        },
        {
          "label": "B",
          "text": "RAYNAUD\u2019S PHENOMENON",
          "correct": false
        },
        {
          "label": "C",
          "text": "ESOPHAGEAL DYSMOTILITY",
          "correct": false
        },
        {
          "label": "D",
          "text": "RENAL FAILURE",
          "correct": true
        }
      ],
      "correct_answer": "D. RENAL FAILURE",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>RENAL FAILURE RENAL FAILURE is not a component of CREST syndrome. CREST syndrome is seen in limited cutaneous systemic sclerosis and consists of the following: Option: A. Calcinosis cutis Option: B. Raynaud\u2019s phenomenon Option: C. Esophageal dysmotility Sclerodactyly Telangiectasia SYSTEMIC SCLERODERMA also known as systemic sclerosis, refers to the hardening of the It can be classified as follows: Systemic scleroderma (eg. Diffuse cutaneous, limited cutaneous) Overlap syndromes Localized scleroderma(e.g morphea, linear scleroderma, eosinophilic fasciitis) Chemically induced scleroderma(e.g with polyvinyl chloride, pentazocine, bleomycin) Pseudosclerodermas(e.g phenylketonuria, scleredema, progeria, and porphyria cutanea tarda) The child presents with skin tightening(edema, atrophy , and acrosclerosis), Raynaud\u2019s phenomenon(blanching, cyanosis &erythema), soft tissue contractures, arthralgias, myalgias & dysphagia, and dyspnea. The presence of ANTI-CENTROMERE Antibody (ACA) is suggestive of a diagnosis of limited cutaneous systemic scleroderma.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1ea4e3f",
      "audio": ""
    },
    {
      "text": "A young girl was diagnosed with systemic sclerosis 6 months back. The girl presented with arthralgias, myalgias, dysphagia, and nail-bed abnormalities. On history taking, the girl revealed that the disease was not recognized initially, but later became significant. The findings upon investigation are: B.P \u2013 180/90 mm hg R.R \u2013 20/min Proteinuria present (indicating renal involvement) Which of the following drugs are implicated in systemic sclerosis of this young girl? Penicillamine Colchicine Cyclophosphamide Nifedipine Bleomycin Select the correct answer from given below code:",
      "options": [
        {
          "label": "A",
          "text": "1,2 & 3",
          "correct": true
        },
        {
          "label": "B",
          "text": "1,2 & 5",
          "correct": false
        },
        {
          "label": "C",
          "text": "2,3 & 5",
          "correct": false
        },
        {
          "label": "D",
          "text": "3,4 & 5",
          "correct": false
        }
      ],
      "correct_answer": "A. 1,2 & 3",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>1,2 & 3 The young girl has been diagnosed with systemic sclerosis and so based on the above clinical features & investigations, the drugs implicated in this condition are: penicillamine and colchicine produces beneficial results in some patients, especially if used early in the course of the disease. Cyclophosphamide(monthly pulses IV), FOLLOWED BY MAINTENANCE DAILY by Azathioprine or weekly Methotrexate. It can be life-saving in patients with interstitial lung disease. Nifedipine is useful in the management of Raynaud\u2019s phenomenon, while Enalapril is used in c ontrolling BP and stabilization of renal function. So, all these drugs are implicated in the management of systemic sclerosis in this young girl. Bleomycin implicated causes chemically induced scleroderma and not systemic sclerosis. The onset of the disease is insidious & difficult to recognize in the initial stages. The child presents with skin tightening(edema, atrophy, and acrosclerosis), Raynaud\u2019s phenomenon(blanching, cyanosis & erythema), soft tissue contractures, arthralgias, myalgias & dysphagia, and dyspnea. An onset of hypertension & proteinuria usually indicates Renal involvement.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a245e310",
      "audio": ""
    }
  ]
}